Savant Capital’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Savant Capital’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,969	Closed	-$335K	–	1243
2025 Q1	$335K	Hold	1,969	–	–	﹤0.01%	797
2024 Q4	$327K	Hold	1,969	–	–	﹤0.01%	1064
2024 Q3	$339K	Hold	1,969	–	–	﹤0.01%	1040
2024 Q2	$303K	Buy	1,969 +433	+28%	+$65K	﹤0.01%	976
2024 Q1	$236K	Buy	+1,536	New	+$234K	﹤0.01%	976

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Savant Capital's FBT Position: Q2 2025 in Review

Savant Capital sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2025, closing a stake of 1,969 shares — an estimated $335K sold.

Savant Capital first reported a position in FBT in Q1 2024 and held it in 5 quarters. The position peaked at $339K in Q3 2024. 250 funds tracked by Wall St. Rank hold FBT as of Q2 2025.

Savant Capital reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2025 after selling out during the quarter.
Savant Capital sold 1,969 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2025, an estimated $335K.
Savant Capital first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2024 and held it in 5 quarters.
Savant Capital's First Trust NYSE Arca Biotechnology Index Fund position peaked at $339K in Q3 2024.
250 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2025.

Based on Savant Capital's 13F filing for Q2 2025, filed 6 Aug 2025.